← Leaderboards
James A Feinstein
University Of Colorado Denver
$2,024,528
Attributed
$2,024,528
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $400K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
AHRQ$1,198,813 · 1
NIH$825,715 · 1
By mechanism
R01$1,198,813 · 1
K23$825,715 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Ernest E Moore$11,236,991
- Halden F Scott$2,091,101
- Ryan G Smith$1,047,066
- Katherine A James$2,528,108
- Andrew Albert Monte$3,733,104
Others in their field
Other Emerging Leaders on “Dosage”
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
- Melissa Allard · Albany Molecular Research, Inc.$8,788,340
- Patrick Boen · Lyndra Therapeutics, Inc.$8,679,033
- Warren David Lo · Virginia Polytechnic Inst And St Univ$7,604,467
- Erin Rooney Riggs · Broad Institute, Inc.$6,471,349
- Montserrat C Anguera · University Of Pennsylvania$6,121,298
Research focus
DosageEmergency SituationAdverse Drug EventAntiepileptic AgentsAreaEmergency Department VisitBiometryCareerCaringCerebral PalsyCharacteristicsChildAssociated SymptomAdultChildhoodClinicColoradoComplex Chronic ConditionsConduct Clinical TrialsConsequentialismData AnalysesDesignDetectionEnsure
Grant awards (8)
Optimizing the Clinical Management of Polypharmacy for Children with Medical Complexity$399,144
R01 · FY2025 · HS · contact PI
Optimizing the Clinical Management of Polypharmacy for Children with Medical Complexity$399,669
R01 · FY2024 · HS · contact PI
Optimizing the Clinical Management of Polypharmacy for Children with Medical Complexity$400,000
R01 · FY2023 · HS · contact PI
Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments$165,143
K23 · FY2021 · HD · contact PI
Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments$165,143
K23 · FY2020 · HD · contact PI
Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments$165,143
K23 · FY2019 · HD · contact PI
Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments$165,143
K23 · FY2018 · HD · contact PI
Enhancing Medication Safety in Children with Polypharmacy Using Parent-Reported Symptom Assessments$165,143
K23 · FY2017 · HD · contact PI